Tapewire

Nasdaq · USD

IDXX

IDEXX LABORATORIES INC /DE

Export transactions ↓
Tapewire entity
3057
SEC CIK
0000874716
Parsed reports
597

Last 12 months

Inside the activity.

0 purchase rows · 36 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202504
Dec 202500
Jan 202600
Feb 2026030
Mar 202601
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 29, 2023 Filed Aug 31, 2023 21:17 UTC
POLEWACZYK JAMES FExecutive Vice President
Exercise / conversionIncentive Stock Option (right-to-buy) · Derivative 706 $0.00 Strike: $141.60 $0.00
Disclosure

SEC source: 0000874716-23-000113 · wk-form4_1693516123.xml · derivative · entry 13

POLEWACZYK JAMES F · CIK 0001389046 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 706 shares

Expires 2027-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: Grant of option to buy 706 shares of Issuer common stock that vested in one installment on February 14, 2022.

Read SEC document
August 29, 2023 Filed Aug 31, 2023 21:17 UTC
POLEWACZYK JAMES FExecutive Vice President
Exercise / conversionNon-Qualified Stock Option (right-to-buy) · Derivative 2,627 $0.00 Strike: $68.75 $0.00
Disclosure

SEC source: 0000874716-23-000113 · wk-form4_1693516123.xml · derivative · entry 12

POLEWACZYK JAMES F · CIK 0001389046 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,627 shares

Expires 2026-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: Grant of option to buy 12,627 shares of Issuer common stock that vested in five annual installments beginning February 14, 2017.

Read SEC document
August 29, 2023 Filed Aug 31, 2023 21:17 UTC
POLEWACZYK JAMES FExecutive Vice President
SaleCommon Stock 2,887 $511.22 $1,475,902.82
Disclosure

SEC source: 0000874716-23-000113 · wk-form4_1693516123.xml · nonDerivative · entry 11

POLEWACZYK JAMES F · CIK 0001389046 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,037.9875

F7 · price: Represents the weighted average price of the shares sold ranging from a low of $510.96 to a high of $511.94 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Read SEC document
August 29, 2023 Filed Aug 31, 2023 21:17 UTC
POLEWACZYK JAMES FExecutive Vice President
SaleCommon Stock 7,473 $511.03 $3,818,916.73
Disclosure

SEC source: 0000874716-23-000113 · wk-form4_1693516123.xml · nonDerivative · entry 10

POLEWACZYK JAMES F · CIK 0001389046 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,924.9875

F6 · price: Represents the weighted average price of the shares sold ranging from a low of $510.73 to a high of $511.67 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Read SEC document
August 29, 2023 Filed Aug 31, 2023 21:17 UTC
POLEWACZYK JAMES FExecutive Vice President
SaleCommon Stock 3,318 $510.47 $1,693,727.52
Disclosure

SEC source: 0000874716-23-000113 · wk-form4_1693516123.xml · nonDerivative · entry 9

POLEWACZYK JAMES F · CIK 0001389046 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,397.9875

F5 · price: Represents the weighted average price of the shares sold ranging from a low of $509.93 to a high of $510.90 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Read SEC document
August 29, 2023 Filed Aug 31, 2023 21:17 UTC
POLEWACZYK JAMES FExecutive Vice President
SaleCommon Stock 6,186 $510.38 $3,157,195.83
Disclosure

SEC source: 0000874716-23-000113 · wk-form4_1693516123.xml · nonDerivative · entry 8

POLEWACZYK JAMES F · CIK 0001389046 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,715.9875

F4 · price: Represents the weighted average price of the shares sold ranging from a low of $509.69 to a high of $510.68 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Read SEC document
August 29, 2023 Filed Aug 31, 2023 21:17 UTC
POLEWACZYK JAMES FExecutive Vice President
SaleCommon Stock 2,545 $509.32 $1,296,221.18
Disclosure

SEC source: 0000874716-23-000113 · wk-form4_1693516123.xml · nonDerivative · entry 7

POLEWACZYK JAMES F · CIK 0001389046 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,901.9875

F3 · price: Represents the weighted average price of the shares sold ranging from a low of $508.63 to a high of $509.63 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Read SEC document
August 29, 2023 Filed Aug 31, 2023 21:17 UTC
POLEWACZYK JAMES FExecutive Vice President
SaleCommon Stock 500 $508.96 $254,482.10
Disclosure

SEC source: 0000874716-23-000113 · wk-form4_1693516123.xml · nonDerivative · entry 6

POLEWACZYK JAMES F · CIK 0001389046 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,446.9875

F2 · price: Represents the weighted average price of the shares sold ranging from a low of $508.76 to a high of $509.42 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Read SEC document
August 29, 2023 Filed Aug 31, 2023 21:17 UTC
POLEWACZYK JAMES FExecutive Vice President
Exercise / conversionCommon Stock 5,865 $178.26 $1,045,494.90
Disclosure

SEC source: 0000874716-23-000113 · wk-form4_1693516123.xml · nonDerivative · entry 5

POLEWACZYK JAMES F · CIK 0001389046 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,946.9875

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 29, 2023 Filed Aug 31, 2023 21:17 UTC
POLEWACZYK JAMES FExecutive Vice President
Exercise / conversionCommon Stock 560 $178.26 $99,825.60
Disclosure

SEC source: 0000874716-23-000113 · wk-form4_1693516123.xml · nonDerivative · entry 4

POLEWACZYK JAMES F · CIK 0001389046 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,081.9875

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 29, 2023 Filed Aug 31, 2023 21:17 UTC
POLEWACZYK JAMES FExecutive Vice President
Exercise / conversionCommon Stock 7,151 $141.60 $1,012,581.60
Disclosure

SEC source: 0000874716-23-000113 · wk-form4_1693516123.xml · nonDerivative · entry 3

POLEWACZYK JAMES F · CIK 0001389046 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,521.9875

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 29, 2023 Filed Aug 31, 2023 21:17 UTC
POLEWACZYK JAMES FExecutive Vice President
Exercise / conversionCommon Stock 706 $141.60 $99,969.60
Disclosure

SEC source: 0000874716-23-000113 · wk-form4_1693516123.xml · nonDerivative · entry 2

POLEWACZYK JAMES F · CIK 0001389046 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,370.9875

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 29, 2023 Filed Aug 31, 2023 21:17 UTC
POLEWACZYK JAMES FExecutive Vice President
Exercise / conversionCommon Stock 2,627 $68.75 $180,606.25
Disclosure

SEC source: 0000874716-23-000113 · wk-form4_1693516123.xml · nonDerivative · entry 1

POLEWACZYK JAMES F · CIK 0001389046 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,664.9875

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes a total of 26.7030 shares purchased under the Issuer's Employee Stock Purchase Plan on March 31, 2023 and June 30, 2023.

Read SEC document
August 15, 2023 Filed Aug 17, 2023 23:37 UTC SaleCommon Stock 492 $0.00 $0.00
Disclosure

SEC source: 0000874716-23-000111 · wk-form4_1692315455.xml · nonDerivative · entry 1

AYERS JONATHAN W · CIK 0001184149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,547

Read SEC document
August 11, 2023 Filed Aug 14, 2023 21:00 UTC GiftCommon Stock 1,000 $0.00 $0.00
Disclosure

SEC source: 0000874716-23-000109 · wk-form4_1692046804.xml · nonDerivative · entry 1

AYERS JONATHAN W · CIK 0001184149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 136,039

Read SEC document
August 05, 2023 Filed Aug 8, 2023 21:59 UTC
MCKEON BRIAN PEVP, CFO and Treasurer
Exercise / conversionRestricted Stock Unit · Derivative 192 Not disclosed Not disclosed
Disclosure

SEC source: 0000874716-23-000107 · wk-form4_1691531977.xml · derivative · entry 4

MCKEON BRIAN P · CIK 0001219445 · EVP, CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,704

Underlying: Common Stock · 192 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning August 5, 2020.

F4 · price: Not applicable.

F3 · derivative.exercise_date: Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning August 5, 2020.

F3 · derivative.expiration_date: Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning August 5, 2020.

Read SEC document
August 05, 2023 Filed Aug 8, 2023 21:59 UTC
MCKEON BRIAN PEVP, CFO and Treasurer
Tax withholdingCommon Stock 117 $504.08 $58,977.36
Disclosure

SEC source: 0000874716-23-000107 · wk-form4_1691531977.xml · nonDerivative · entry 2

MCKEON BRIAN P · CIK 0001219445 · EVP, CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,692.3456

F2 · price: Closing price of Issuer common stock on NASDAQ market on August 4, 2023.

Read SEC document
August 05, 2023 Filed Aug 8, 2023 21:59 UTC
MCKEON BRIAN PEVP, CFO and Treasurer
Exercise / conversionCommon Stock 192 $0.00 $0.00
Disclosure

SEC source: 0000874716-23-000107 · wk-form4_1691531977.xml · nonDerivative · entry 1

MCKEON BRIAN P · CIK 0001219445 · EVP, CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,809.3456

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 12 shares purchased under the Issuer's Employee Stock Purchase Plan on June 30, 2023.

Read SEC document
August 05, 2023 Filed Aug 8, 2023 21:59 UTC
MAZELSKY JONATHAN JAYDirector · President and CEO
Exercise / conversionRestricted Stock Unit · Derivative 384 Not disclosed Not disclosed
Disclosure

SEC source: 0000874716-23-000106 · wk-form4_1691531933.xml · derivative · entry 3

MAZELSKY JONATHAN JAY · CIK 0001556270 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,443

Underlying: Common Stock · 384 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning August 5, 2020.

F4 · price: Not applicable.

F3 · derivative.exercise_date: Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning August 5, 2020.

F3 · derivative.expiration_date: Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning August 5, 2020.

Read SEC document
August 05, 2023 Filed Aug 8, 2023 21:59 UTC
MAZELSKY JONATHAN JAYDirector · President and CEO
Tax withholdingCommon Stock 170 $504.08 $85,693.60
Disclosure

SEC source: 0000874716-23-000106 · wk-form4_1691531933.xml · nonDerivative · entry 2

MAZELSKY JONATHAN JAY · CIK 0001556270 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,925.3456

F2 · price: Closing price of Issuer common stock on NASDAQ market on August 4, 2023.

Read SEC document
August 05, 2023 Filed Aug 8, 2023 21:59 UTC
MAZELSKY JONATHAN JAYDirector · President and CEO
Exercise / conversionCommon Stock 384 $0.00 $0.00
Disclosure

SEC source: 0000874716-23-000106 · wk-form4_1691531933.xml · nonDerivative · entry 1

MAZELSKY JONATHAN JAY · CIK 0001556270 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,095.3456

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 12 shares purchased under the Issuer's Employee Stock Purchase Plan on June 30, 2023.

Read SEC document
August 03, 2023 Filed Aug 7, 2023 21:04 UTC
Lane MichaelExecutive Vice President
Exercise / conversionIncentive Stock Option (right-to-buy) · Derivative 7,080 $0.00 Strike: $206.94 $0.00
Disclosure

SEC source: 0000874716-23-000103 · wk-form4_1691442284.xml · derivative · entry 8

Lane Michael · CIK 0001740689 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,286

Underlying: Common Stock · 7,080 shares

Expires 2029-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: Grant of option to buy 8,366 shares of Issuer common stock that vested in five annual installments beginning February 14, 2020.

Read SEC document
August 03, 2023 Filed Aug 7, 2023 21:04 UTC
Lane MichaelExecutive Vice President
Exercise / conversionIncentive Stock Option (right-to-buy) · Derivative 7,435 $0.00 Strike: $178.26 $0.00
Disclosure

SEC source: 0000874716-23-000103 · wk-form4_1691442284.xml · derivative · entry 7

Lane Michael · CIK 0001740689 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,435 shares

Expires 2028-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Grant of option to buy 9,434 shares of Issuer common stock that vested in five annual installments beginning February 14, 2019.

Read SEC document
August 03, 2023 Filed Aug 7, 2023 21:04 UTC
Lane MichaelExecutive Vice President
Exercise / conversionIncentive Stock Option (right-to-buy) · Derivative 1,512 $0.00 Strike: $141.60 $0.00
Disclosure

SEC source: 0000874716-23-000103 · wk-form4_1691442284.xml · derivative · entry 6

Lane Michael · CIK 0001740689 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,512 shares

Expires 2027-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Grant of option to buy 10,386 shares of Issuer common stock that vested in five annual installments beginning February 14, 2018.

Read SEC document
August 03, 2023 Filed Aug 7, 2023 21:04 UTC
Lane MichaelExecutive Vice President
SaleCommon Stock 16,027 $510.00 $8,173,770.00
Disclosure

SEC source: 0000874716-23-000103 · wk-form4_1691442284.xml · nonDerivative · entry 4

Lane Michael · CIK 0001740689 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,033.9875

F2 · price: Represents the weighted average price of the shares sold ranging from a low of $510.00 to a high of $510.10 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Read SEC document
August 03, 2023 Filed Aug 7, 2023 21:04 UTC
Lane MichaelExecutive Vice President
Exercise / conversionCommon Stock 7,080 $206.94 $1,465,135.20
Disclosure

SEC source: 0000874716-23-000103 · wk-form4_1691442284.xml · nonDerivative · entry 3

Lane Michael · CIK 0001740689 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,060.9875

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 03, 2023 Filed Aug 7, 2023 21:04 UTC
Lane MichaelExecutive Vice President
Exercise / conversionCommon Stock 7,435 $178.26 $1,325,363.10
Disclosure

SEC source: 0000874716-23-000103 · wk-form4_1691442284.xml · nonDerivative · entry 2

Lane Michael · CIK 0001740689 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,980.9875

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 03, 2023 Filed Aug 7, 2023 21:04 UTC
Lane MichaelExecutive Vice President
Exercise / conversionCommon Stock 1,512 $141.60 $214,099.20
Disclosure

SEC source: 0000874716-23-000103 · wk-form4_1691442284.xml · nonDerivative · entry 1

Lane Michael · CIK 0001740689 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,545.9875

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 12 shares purchased under the Issuer's Employee Stock Purchase Plan on June 30, 2023.

Read SEC document
July 28, 2023 Filed Aug 1, 2023 21:19 UTC GrantCommon Stock 14 $552.78 $7,738.92
Disclosure

SEC source: 0000874716-23-000101 · wk-form4_1690924784.xml · nonDerivative · entry 1

JUNIUS DANIEL M · CIK 0001094159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,009

F1 · shares: Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the "Plan") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($7,500.00) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock as soon as practicable following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan.

Read SEC document
May 19, 2023 Filed May 22, 2023 21:00 UTC Exercise / conversionNon-Qualified Stock Option (right-to-buy) · Derivative 10,000 Not disclosed Strike: $79.54 Not disclosed
Disclosure

SEC source: 0000874716-23-000086 · wf-form4_168478920867596.xml · derivative · entry 22

AYERS JONATHAN W · CIK 0001184149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,540

Underlying: Common Stock · 10,000 shares

Expires 2025-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F19 · price: Not applicable.

F18 · derivative.exercise_date: Grant of option to buy 74,316 shares of IDEXX Laboratories, Inc. common stock that became exercisable in five equal annual installments beginning on February 14, 2016 without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.

Read SEC document
May 19, 2023 Filed May 22, 2023 21:00 UTC SaleCommon Stock 300 $498.48 $149,544.00
Disclosure

SEC source: 0000874716-23-000086 · wf-form4_168478920867596.xml · nonDerivative · entry 18

AYERS JONATHAN W · CIK 0001184149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 137,039

F16 · price: Represents the weighted average price of the shares sold ranging from a low of $498.47 to a high of $498.50 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Read SEC document
May 19, 2023 Filed May 22, 2023 21:00 UTC SaleCommon Stock 759 $497.66 $377,720.60
Disclosure

SEC source: 0000874716-23-000086 · wf-form4_168478920867596.xml · nonDerivative · entry 17

AYERS JONATHAN W · CIK 0001184149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 137,339

F15 · price: Represents the weighted average price of the shares sold ranging from a low of $497.00 to a high of $497.99 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Read SEC document
May 19, 2023 Filed May 22, 2023 21:00 UTC SaleCommon Stock 886 $495.94 $439,398.50
Disclosure

SEC source: 0000874716-23-000086 · wf-form4_168478920867596.xml · nonDerivative · entry 16

AYERS JONATHAN W · CIK 0001184149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 138,098

F14 · price: Represents the weighted average price of the shares sold ranging from a low of $495.53 to a high of $496.45 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Read SEC document
May 19, 2023 Filed May 22, 2023 21:00 UTC SaleCommon Stock 1,229 $494.28 $607,465.20
Disclosure

SEC source: 0000874716-23-000086 · wf-form4_168478920867596.xml · nonDerivative · entry 15

AYERS JONATHAN W · CIK 0001184149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 138,984

F13 · price: Represents the weighted average price of the shares sold ranging from a low of $493.37 to a high of $494.53 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Read SEC document
May 19, 2023 Filed May 22, 2023 21:00 UTC SaleCommon Stock 1,426 $492.82 $702,756.61
Disclosure

SEC source: 0000874716-23-000086 · wf-form4_168478920867596.xml · nonDerivative · entry 14

AYERS JONATHAN W · CIK 0001184149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 140,213

F12 · price: Represents the weighted average price of the shares sold ranging from a low of $492.38 to a high of $493.31 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Read SEC document
May 19, 2023 Filed May 22, 2023 21:00 UTC SaleCommon Stock 400 $491.59 $196,636.00
Disclosure

SEC source: 0000874716-23-000086 · wf-form4_168478920867596.xml · nonDerivative · entry 13

AYERS JONATHAN W · CIK 0001184149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 141,639

F11 · price: Represents the weighted average price of the shares sold ranging from a low of $491.36 to a high of $491.74 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Read SEC document
May 19, 2023 Filed May 22, 2023 21:00 UTC SaleCommon Stock 300 $490.03 $147,008.49
Disclosure

SEC source: 0000874716-23-000086 · wf-form4_168478920867596.xml · nonDerivative · entry 12

AYERS JONATHAN W · CIK 0001184149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 142,039

F10 · price: Represents the weighted average price of the shares sold ranging from a low of $489.865 to a high of $490.11 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Read SEC document
May 19, 2023 Filed May 22, 2023 21:00 UTC SaleCommon Stock 1,308 $488.77 $639,317.44
Disclosure

SEC source: 0000874716-23-000086 · wf-form4_168478920867596.xml · nonDerivative · entry 11

AYERS JONATHAN W · CIK 0001184149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 142,339

F9 · price: Represents the weighted average price of the shares sold ranging from a low of $488.41 to a high of $489.35 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Read SEC document
May 19, 2023 Filed May 22, 2023 21:00 UTC SaleCommon Stock 2,254 $487.82 $1,099,539.29
Disclosure

SEC source: 0000874716-23-000086 · wf-form4_168478920867596.xml · nonDerivative · entry 10

AYERS JONATHAN W · CIK 0001184149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 143,647

F8 · price: Represents the weighted average price of the shares sold ranging from a low of $487.34 to a high of $488.32 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Read SEC document
May 19, 2023 Filed May 22, 2023 21:00 UTC SaleCommon Stock 1,138 $486.92 $554,116.21
Disclosure

SEC source: 0000874716-23-000086 · wf-form4_168478920867596.xml · nonDerivative · entry 9

AYERS JONATHAN W · CIK 0001184149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 145,901

F7 · price: Represents the weighted average price of the shares sold ranging from a low of $486.29 to a high of $487.27 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Read SEC document
May 19, 2023 Filed May 22, 2023 21:00 UTC Exercise / conversionCommon Stock 10,000 $79.54 $795,400.00
Disclosure

SEC source: 0000874716-23-000086 · wf-form4_168478920867596.xml · nonDerivative · entry 8

AYERS JONATHAN W · CIK 0001184149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 147,039

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 18, 2023 Filed May 19, 2023 21:04 UTC
MAZELSKY JONATHAN JAYDirector · President and CEO
GiftCommon Stock 602 $0.00 $0.00
Disclosure

SEC source: 0000874716-23-000084 · wf-form4_168453026450198.xml · nonDerivative · entry 1

MAZELSKY JONATHAN JAY · CIK 0001556270 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,699.3456

Read SEC document
May 18, 2023 Filed May 22, 2023 21:00 UTC Exercise / conversionNon-Qualified Stock Option (right-to-buy) · Derivative 10,000 Not disclosed Strike: $79.54 Not disclosed
Disclosure

SEC source: 0000874716-23-000086 · wf-form4_168478920867596.xml · derivative · entry 21

AYERS JONATHAN W · CIK 0001184149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,540

Underlying: Common Stock · 10,000 shares

Expires 2025-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F19 · price: Not applicable.

F18 · derivative.exercise_date: Grant of option to buy 74,316 shares of IDEXX Laboratories, Inc. common stock that became exercisable in five equal annual installments beginning on February 14, 2016 without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.

Read SEC document
May 18, 2023 Filed May 22, 2023 21:00 UTC SaleCommon Stock 1,298 $491.91 $638,493.73
Disclosure

SEC source: 0000874716-23-000086 · wf-form4_168478920867596.xml · nonDerivative · entry 7

AYERS JONATHAN W · CIK 0001184149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 137,039

F6 · price: Represents the weighted average price of the shares sold ranging from a low of $491.54 to a high of $492.345 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Read SEC document
May 18, 2023 Filed May 22, 2023 21:00 UTC SaleCommon Stock 1,695 $490.77 $831,858.37
Disclosure

SEC source: 0000874716-23-000086 · wf-form4_168478920867596.xml · nonDerivative · entry 6

AYERS JONATHAN W · CIK 0001184149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 138,337

F5 · price: Represents the weighted average price of the shares sold ranging from a low of $490.375 to a high of $491.30 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Read SEC document
May 18, 2023 Filed May 22, 2023 21:00 UTC SaleCommon Stock 2,242 $489.71 $1,097,925.56
Disclosure

SEC source: 0000874716-23-000086 · wf-form4_168478920867596.xml · nonDerivative · entry 5

AYERS JONATHAN W · CIK 0001184149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 140,032

F4 · price: Represents the weighted average price of the shares sold ranging from a low of $489.32 to a high of $490.32 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Read SEC document
May 18, 2023 Filed May 22, 2023 21:00 UTC SaleCommon Stock 1,012 $488.63 $494,497.91
Disclosure

SEC source: 0000874716-23-000086 · wf-form4_168478920867596.xml · nonDerivative · entry 4

AYERS JONATHAN W · CIK 0001184149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 142,274

F3 · price: Represents the weighted average price of the shares sold ranging from a low of $488.21 to a high of $489.02 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Read SEC document
May 18, 2023 Filed May 22, 2023 21:00 UTC SaleCommon Stock 2,753 $487.84 $1,343,010.58
Disclosure

SEC source: 0000874716-23-000086 · wf-form4_168478920867596.xml · nonDerivative · entry 3

AYERS JONATHAN W · CIK 0001184149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 143,286

F2 · price: Represents the weighted average price of the shares sold ranging from a low of $487.19 to a high of $488.19 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Read SEC document
May 18, 2023 Filed May 22, 2023 21:00 UTC SaleCommon Stock 1,000 $486.48 $486,482.00
Disclosure

SEC source: 0000874716-23-000086 · wf-form4_168478920867596.xml · nonDerivative · entry 2

AYERS JONATHAN W · CIK 0001184149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 146,039

F1 · price: Represents the weighted average price of the shares sold ranging from a low of $486.08 to a high of $487.03 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Read SEC document
May 18, 2023 Filed May 22, 2023 21:00 UTC Exercise / conversionCommon Stock 10,000 $79.54 $795,400.00
Disclosure

SEC source: 0000874716-23-000086 · wf-form4_168478920867596.xml · nonDerivative · entry 1

AYERS JONATHAN W · CIK 0001184149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 147,039

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.